"Compounding pharmacies who provide GLP-1 drugs -- and not just for weight loss but many other conditions -- can still do that but we're also making sure that bad actors -- grey and black markets -- who are deceptively advertising to patients, that it's FDA approved, that those folks are mandated that they cannot do that anymore." The bill would also make false or misleading claims about the compounded drugs a Deceptive Trade Practice
Although both drugs contain tirzepatide, their side effects are not the same
Spironolactone is frequently used alongside other treatments to improve outcomes for PCOS-related hair loss
Furthermore, different class of drugs may not offer the same benefits of Ozempic and other GLP-1 agonists, such as protecting the kidneys or decreasing the risk of heart disease
Some individuals may achieve even greater results
Remarkably, while inhibiting GLP-1R-expressing neurons in the AP prevents the aversion caused by exendin-4 and semaglutide, the chronic inhibitory effects of the two GLP-1R agonists on food intake and body weight are preserved [34, 58]